ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $51.5M

      Shares

      1.14M

      % of Portfolio

      0.04%

      Average Buy Price

      $50.4

      Avg closing price
      Price range

      44 PRIMECAP Management Sanofi Trades

      PRIMECAP Management's position in Sanofi is currently worth $51.5M. That's 0.04% of their equity portfolio (191st largest holding). The first Sanofi trade was made in Q1 2013. Since then PRIMECAP Management bought shares eight more times and sold shares on 35 occasions. The investor's estimated purchase price is $57.2M, resulting in a loss of 10%.

      Avg closing price
      Price range
      Increased shares by 3.2% (+34.9k shares) Q2 2025
      Avg closing price $51.07
      Price range $47.62 - $55.44
      Sold 0.9% shares (-10.3k shares) Q1 2025
      Avg closing price $54.00
      Price range $48.15 - $59.42
      Sold 0.5% shares (-5.07k shares) Q4 2024
      Avg closing price $50.75
      Price range $45.89 - $57.31
      Sold 0.1% shares (-1.33k shares) Q3 2024
      Avg closing price $53.95
      Price range $48.54 - $58.53
      Sold 0.2% shares (-2.12k shares) Q2 2024
      Avg closing price $48.24
      Price range $45.39 - $50.36
      Sold 0.3% shares (-3.58k shares) Q1 2024
      Avg closing price $48.83
      Price range $45.75 - $52.48
      Sold 0.4% shares (-3.96k shares) Q4 2023
      Avg closing price $48.90
      Price range $43.13 - $54.79
      Sold 0.5% shares (-5.1k shares) Q3 2023
      Avg closing price $53.32
      Price range $50.95 - $55.20
      Sold 4.8% shares (-57k shares) Q2 2023
      Avg closing price $53.81
      Price range $50.45 - $57.18
      Sold 2.2% shares (-26.7k shares) Q1 2023
      Avg closing price $48.64
      Price range $45.86 - $54.45
      Sold 1.9% shares (-23.8k shares) Q4 2022
      Avg closing price $43.89
      Price range $38.86 - $48.55
      Sold 0.5% shares (-5.94k shares) Q2 2022
      Avg closing price $53.08
      Price range $48.99 - $57.46
      Sold 0.4% shares (-4.42k shares) Q1 2022
      Avg closing price $51.64
      Price range $48.48 - $53.65
      Sold 7.3% shares (-98.5k shares) Q4 2021
      Avg closing price $49.46
      Price range $47.07 - $52.35
      Sold 2.3% shares (-31.8k shares) Q3 2021
      Avg closing price $50.85
      Price range $47.89 - $53.12
      Sold 0.9% shares (-12.5k shares) Q2 2021
      Avg closing price $52.18
      Price range $49.36 - $54.25
      Sold 18.3% shares (-311k shares) Q1 2021
      Avg closing price $48.04
      Price range $45.46 - $50.51
      Sold 2.2% shares (-38.6k shares) Q4 2020
      Avg closing price $49.32
      Price range $45.30 - $51.62
      Sold 4.2% shares (-75.5k shares) Q3 2020
      Avg closing price $51.48
      Price range $49.47 - $53.77
      Sold 2.3% shares (-42.9k shares) Q2 2020
      Avg closing price $48.60
      Price range $42.91 - $52.50

      News about Sanofi - ADR and PRIMECAP Management

      Reuter James Wealth Management LLC Buys 2,524 Shares of Sanofi (NASDAQ:SNY)

      Reuter James Wealth Management LLC Buys 2,524 Shares of Sanofi (NASDAQ:SNY)

      ¡­ Analysis on SNY About Sanofi (Free Report) Sanofi , a healthcare company, ¡­ , and internationally. It operates through Pharmaceuticals , Vaccines, and Cons...

      EIN News Pharmaceuticals EIN News Pharmaceuticals, almost 2 years ago
      Keudell Morrison Wealth Management Increases Stock Holdings in Sanofi (NASDAQ:SNY)

      Keudell Morrison Wealth Management Increases Stock Holdings in Sanofi (NASDAQ:SNY)

      ¡­ funds and other institutional investors. Sanofi Stock Performance Shares of NASDAQ ¡­ Report on SNY Sanofi Company Profile (Free Report) Sanofi , a healthca...

      EIN News Pharmaceuticals EIN News Pharmaceuticals, almost 2 years ago
      Sanofi (SNY) Management Presents at Cowen 42nd Annual Healthcare Conference (Transcript)

      Sanofi (SNY) Management Presents at Cowen 42nd Annual Healthcare Conference (Transcript)

      No summary available.

      Seeking Alpha Seeking Alpha, over 3 years ago
      Biocorp: Sanofi and Roche Diabetes Care France Join Forces to Improve the Management of Diabetes With the Connected Device Mallya for Solostar

      Biocorp: Sanofi and Roche Diabetes Care France Join Forces to Improve the Management of Diabetes With the Connected Device Mallya for Solostar

      Regulatory News: Sanofi and Roche Diabetes Care France two leaders convinced of the added value of new technologies for better management and personalized su...

      FinanzNachrichten FinanzNachrichten, almost 4 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×